A detailed history of Profund Advisors LLC transactions in Organon & Co. stock. As of the latest transaction made, Profund Advisors LLC holds 29,825 shares of OGN stock, worth $439,322. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,825
Previous 29,410 1.41%
Holding current value
$439,322
Previous $608,000 6.25%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.65 - $23.03 $7,739 - $9,557
415 Added 1.41%
29,825 $570,000
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $205,805 - $258,996
-11,794 Reduced 28.62%
29,410 $608,000
Q1 2024

May 08, 2024

SELL
$13.78 - $18.8 $241,260 - $329,150
-17,508 Reduced 29.82%
41,204 $774,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $261,748 - $414,017
23,904 Added 68.67%
58,712 $846,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $55,244 - $79,154
3,330 Added 10.58%
34,808 $604,000
Q2 2023

Aug 10, 2023

BUY
$19.27 - $24.63 $41,623 - $53,200
2,160 Added 7.37%
31,478 $655,000
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $162,042 - $242,685
7,565 Added 34.78%
29,318 $689,000
Q4 2022

Feb 02, 2023

BUY
$23.31 - $28.61 $41,864 - $51,383
1,796 Added 9.0%
21,753 $607,000
Q3 2022

Nov 04, 2022

SELL
$23.4 - $34.25 $25,997 - $38,051
-1,111 Reduced 5.27%
19,957 $467,000
Q2 2022

Aug 01, 2022

BUY
$31.66 - $38.9 $31,533 - $38,744
996 Added 4.96%
21,068 $711,000
Q1 2022

May 10, 2022

SELL
$30.45 - $39.36 $30,084 - $38,887
-988 Reduced 4.69%
20,072 $701,000
Q4 2021

Feb 08, 2022

SELL
$28.67 - $37.13 $4,902 - $6,349
-171 Reduced 0.81%
21,060 $641,000
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $69,542 - $86,569
-2,429 Reduced 10.27%
21,231 $696,000
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $673,127 - $899,080
23,660 New
23,660 $716,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.